Navigation Links
Drugs Watchdog Faces A Judicial Review

The NHS drugs watchdog will be facing a judicial review in court for the first time. Eisai and Pfizer have been permitted a legal review// over the health watchdog's refusal to approve drugs to treat Alzheimer's disease.

According to the National Institute for Health and Clinical Excellence (Nice), people who are either in the early or in the later stages of Alzheimer's disease cannot be treated with medicines on the NHS. But Eisai and Pfizer mark such assumptions of Nice as ‘irrational’.

Last year Nice declined an appeal over its pronouncement that sufferers with early or late-stage Alzheimer's should not have access to Aricept (donepezil), Reminyl galantamine) or Exelon (rivastigmine). Ebixa (memantine) can be used in clinical studies for sufferers with moderate to severe conditions of Alzheimer's disease.

Judicial review regarding Aricept has been granted to Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner. This was announced by the companies. Reminyl and Exelon will also be reviewed. As per the activists, patients in the early stages of Alzheimer's also should have access to these drugs which cost around £2.50 a day.

Neil Hunt, chief executive of the Alzheimer's Society which is also involved in this legal battle feels that denying treatment to people who suffer from this devastating disease in the early stages is cruel and unethical. He also added that their legal team will go on to prove that decision of Nice is fundamentally flawed.
JT
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson ... offers insurance and financial preparation services, is providing an update on a charitable ... , Rock City Rescue is a locally recognized nonprofit that provides shelter and ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: